Three Regulatory Fronts Quietly Reshaping Veterinary Practice — And What You Must Do Before the Windows Close
Veterinary medicine does not change only in the clinic. It changes in federal agency conference rooms, state administrative hearings, and legislative committee sessions where the rules governing what practitioners can prescribe, who can perform which procedures, and how controlled substances must be handled are written, revised, and sometimes rewritten without the full attention of the profession they govern.
At present, three distinct but interconnected regulatory fronts are advancing simultaneously — each with real consequences for clinical practice and economic sustainability. Understanding these battles, identifying the key players on each front, and knowing precisely how to engage before decision windows close is not optional for the engaged practitioner. It is professional self-defense.
Front One: DEA Rulemaking and the Future of Veterinary Controlled Substance Management
The Drug Enforcement Administration's regulatory framework for controlled substances was not designed with veterinary medicine as a primary consideration. It was built around human healthcare and has been adapted — imperfectly — to the realities of veterinary practice for decades. That adaptation is now under active renegotiation.
What Is Happening
In recent years, the DEA has been revisiting several aspects of how veterinary practitioners register, store, dispense, and document controlled substances, in part driven by broader federal concerns about the opioid crisis and diversion risks. Proposed and finalized rules have addressed issues including DEA registration requirements for multi-location practices, telemedicine prescribing of controlled substances (a question that became acute during the COVID-19 pandemic and has not been fully resolved), and record-keeping standards that some practitioners argue impose disproportionate administrative burdens on small and rural practices.
Of particular concern to the veterinary community is the question of whether the DEA's evolving telemedicine prescribing rules — developed primarily in response to human telehealth — will create workable pathways for veterinarians practicing in underserved rural areas where in-person examination prior to controlled substance prescribing may be logistically difficult or genuinely harmful to animal welfare.
The Clinical and Economic Stakes
For a rural large-animal practitioner managing pain protocols for livestock or a small-animal clinician handling post-surgical care, the practical implications of DEA rulemaking are immediate. Overly restrictive rules can delay pain management, increase administrative overhead, and create compliance liability for practitioners who are already managing complex caseloads with limited staff. For practices operating across multiple locations — a growing model in corporate veterinary medicine — registration and record-keeping requirements can generate significant operational costs.
Key Players and How to Engage
The DEA's Diversion Control Division is the primary regulatory body. The American Veterinary Medical Association (AVMA) monitors DEA rulemaking closely and submits formal comments on behalf of the profession. However, individual practitioner comments carry independent weight in the federal rulemaking process — agency staff are required to consider all substantive comments received during public comment periods.
When a Notice of Proposed Rulemaking (NPRM) relevant to veterinary controlled substance practice is published in the Federal Register, veterinarians have a defined window — typically 30 to 60 days — to submit formal comments through Regulations.gov. Comments should be specific, grounded in clinical experience, and address the proposed rule's language directly rather than offering general objections. VetPAC strongly encourages practitioners to sign up for AVMA regulatory alerts and to designate a staff member or practice manager responsible for monitoring the Federal Register for relevant DEA notices.
Front Two: Interstate Prescription Authority and the Unresolved Jurisdictional Conflict
As veterinary telemedicine has expanded — accelerated significantly by pandemic-era practice disruptions — a fundamental regulatory tension has come into sharper focus: veterinary licensure is state-based, but the patients, practitioners, and prescriptions involved in telehealth consultations routinely cross state lines.
What Is Happening
Several states have enacted or are considering legislation that restricts the ability of out-of-state veterinarians to prescribe medications for animals located within their borders, even in the context of a legitimate telehealth consultation. The underlying concern — protecting the validity of the veterinarian-client-patient relationship (VCPR) — is legitimate. But the patchwork of inconsistent state VCPR definitions and prescription authority rules is creating genuine confusion for practitioners, pharmacies, and clients.
At the federal level, there is ongoing discussion about whether a federal VCPR standard should preempt state definitions for the purpose of telemedicine prescribing — a proposal that has generated significant debate within the profession itself, with some practitioners welcoming federal clarity and others wary of federal encroachment on state-regulated professional practice.
Additionally, the question of whether veterinary prescription drugs can be dispensed across state lines by online pharmacies — and under what conditions — remains contested, with implications for both practitioner prescription authority and client access to medications.
The Clinical and Economic Stakes
For practitioners in border communities, multi-state rural practices, and emerging telehealth platforms, the current regulatory ambiguity creates real liability exposure. A veterinarian who prescribes for a client who has relocated across a state line — or who consults remotely on a case involving an animal in another state — may be operating in a legal gray zone that neither state has clearly resolved. For clients in rural or underserved areas, inconsistent interstate prescription rules can translate directly into delayed or denied access to medications their animals need.
Key Players and How to Engage
The relevant players here include state veterinary licensing boards, state legislatures, the AVMA's Veterinary Telemedicine Task Force, and — for the federal preemption question — the House and Senate agriculture committees. The National Association of State Departments of Agriculture (NASDA) and the American Association of Veterinary State Boards (AAVSB) are also active in this space.
Practitioners should contact their state veterinary medical association to understand how their specific state currently defines the VCPR for telemedicine purposes and whether any legislation affecting interstate prescription authority is pending. For the federal dimension, reaching out to the offices of members who sit on the Senate Committee on Agriculture, Nutrition, and Forestry or the House Committee on Agriculture — particularly those representing rural districts — is an effective point of entry.
Front Three: Technician Scope-of-Practice Expansion and What It Means for the Profession
The third regulatory front is perhaps the most politically complex because it involves a genuine tension between two legitimate interests: addressing the veterinary workforce shortage and protecting the standards of care that define the profession.
What Is Happening
In response to documented shortages of licensed veterinarians — particularly in rural and underserved areas — a growing number of state legislatures and veterinary boards are considering proposals that would expand the scope of practice for veterinary technicians and technologists. These proposals range from relatively modest adjustments (allowing credentialed technicians to perform certain procedures under indirect rather than direct supervision) to more sweeping changes (creating new categories of veterinary paraprofessionals with independent practice authority in defined settings).
At the federal level, legislation such as the Veterinary Medicine Loan Repayment Program and related workforce initiatives has drawn attention to the structural supply problem. Some advocates argue that scope-of-practice expansion is a necessary complement to workforce development efforts; others contend that it addresses symptoms rather than root causes and introduces patient safety risks.
The Clinical and Economic Stakes
For practice owners, scope-of-practice changes affect staffing models, liability exposure, supervision requirements, and the economics of service delivery. For employed veterinarians, they raise questions about professional identity, responsibility, and the boundaries of the doctor-patient relationship. For veterinary technicians themselves, expanded scope can mean greater professional recognition and career advancement — a consideration that deserves honest engagement rather than dismissal.
The stakes are not abstract. In states where scope-of-practice proposals have advanced, practitioners have reported confusion about liability boundaries, difficulty obtaining clear guidance from licensing boards, and tension within practice teams navigating newly ambiguous role definitions.
Key Players and How to Engage
State veterinary medical boards are the primary regulatory authority on scope-of-practice questions. Most boards hold public comment periods when considering rule changes, and practitioner participation in those processes is both appropriate and influential. State legislatures are also active on this front — veterinary associations in states including California, Texas, and Virginia have engaged directly with legislative proposals affecting technician practice authority.
At the national level, the AVMA's policy statements on veterinary supervision and technician scope of practice provide a framework that state associations can reference in their advocacy. The National Association of Veterinary Technicians in America (NAVTA) is a key stakeholder whose perspective reflects the technician community's interests and should be engaged constructively rather than treated as an adversary.
Acting Before the Windows Close
Each of these three regulatory fronts is moving on its own timeline, with its own set of decision points and comment opportunities. The common thread is that practitioners who engage — who submit comments, contact their legislators, participate in board proceedings, and stay informed through their professional associations — shape outcomes. Those who do not cede that influence to others.
VetPAC recommends three immediate steps for every veterinary practitioner:
- Subscribe to regulatory alert services through the AVMA and your state veterinary medical association to receive timely notification of proposed rules and comment deadlines.
- Identify your federal and state representatives on agriculture and health committees and introduce yourself through a brief, professional communication that establishes you as a constituent resource on veterinary policy matters.
- Engage your state veterinary medical association to understand which of these three fronts is most active in your jurisdiction and what specific actions are needed in the next 90 days.
The regulatory landscape of veterinary medicine is being written right now. The profession's voice belongs in that process — and the window to use it is open, but not indefinitely.
